𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cause and prognosis in acute liver failure

✍ Scribed by Riordan, Stephen M. ;Williams, Roger


Publisher
Wiley (John Wiley & Sons)
Year
1999
Tongue
English
Weight
44 KB
Volume
5
Category
Article
ISSN
1074-3022

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Gc-globulin and prognosis in acute liver
✍ Frank V. SchiΓΈdt; Lorenzo Rossaro; Richard T. Stravitz; A. Obaid Shakil; Raymond πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 1 views

Serum concentrations of the actin scavenger Gc-globulin are reduced in acute liver failure (ALF). Prospectively, we tested Gc-globulin's value to predict outcome following ALF using sera from 182 patients with ALF from the U.S. ALF Study Group. Admission serum levels of Gc-globulin (normal range: 35

Alpha-fetoprotein and prognosis in acute
✍ Frank V. SchiΓΈdt; George Ostapowicz; Natalie Murray; Raj Satyanarana; Atif Zaman πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 1 views

Serum concentrations of alpha-fetoprotein (AFP), variably elevated during liver injury, have been suggested to be of prognostic importance in acute liver failure (ALF), higher values being associated with improved outcome. Using a nephelometric assay, we measured AFP in sera obtained on admission fr

Etiology and prognosis of acute liver fa
✍ Anil Dhawan πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

## Key Points 1. The etiology of acute liver failure in children differs from that in adults, with metabolic conditions being commoner in Europe and North America and hepatitis A being the commonest cause in Asia and South America. 2. Encephalopathy usually is a late feature and is not essential fo

Imatinib mesylate as a cause of acute li
✍ Timothy J.S. Cross; Catherine Bagot; Bernard Portmann; Julia Wendon; D. Gillett πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 2 views

A 46-year-old patient diagnosed with chronic myeloid leukemia in whom cytogenetic and molecular remission had never been achieved was commenced on Imatinib Mesylate (GleevecΓ’, Novartis Pharmaceuticals Corp., East Hanover, NJ). After 18 months of treatment, she developed abnormal liver function tests

Acute liver failure in India
✍ M S Khuroo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

To the Editor: diac interaction would not constitute definitive proof of the I read with great interest the paper by Mohamed et al. 1 hypothesis, nor would possible parallel mechanisms (e.g., documenting a prolonged QT cmax in patients with end-stage autonomic) necessarily be excluded. liver disease